
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BIOX | Paris | EUR | Real-time | |
BIMp | BATS Europe | EUR | Delayed | |
BIMX | Vienna | EUR | Real-time |
bioMérieux S.A. develops and markets in vitro diagnostic solutions for infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemase producing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO or 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDAS, a specific marker of severe bacterial infections/sepsis. It also develops Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. It has partnership with Boehringer Ingelheim and Evotec. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Name | Age | Since | Title |
---|---|---|---|
Alexandre Merieux | 50 | 2004 | Chairman |
Alain Merieux | 86 | 1965 | Founding Chairman |
Harold Y. H. Boel | 60 | 2012 | Independent Director |
Fanny Letier | 45 | 2017 | Independent Director |
Philippe Archinard | 65 | 2010 | Non-Independent Director |
Marie-Helene Habert-Dassault | 59 | 2012 | Independent Director |
Jean-Luc Belingard | 76 | 2006 | Non-Independent Director |
Marie-Paule Kieny | 69 | 2017 | Independent Director |
Sylvain Orenga | 59 | 2022 | Employee Representative Director |
Viviane Monges | 62 | 2024 | Independent Director |
Benoit Ribadeau-Dumas | 53 | 2024 | Censor of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review